Minoru Kodama
Director/Board Member at KAWAMOTO CORPORATION
Profile
Minoru Kodama is currently an Independent Outside Director at Kawamoto Corp.
since 2022.
He is also a Senior Managing Director at Medisa Shinyaku, Inc. since 2008 and a Director at Kaken Shoyaku KK since 2007.
Previously, he worked as a Director, GM-Administration & Deputy GM-Sales at Sawai Pharmaceutical Co., Ltd.
from 2013 to 2018.
He also held a position as Manager-Third Division Screening at UFJ Bank Ltd.
Minoru Kodama active positions
Companies | Position | Start |
---|---|---|
KAWAMOTO CORPORATION | Director/Board Member | 2022-06-20 |
Medisa Shinyaku, Inc.
Medisa Shinyaku, Inc. Pharmaceuticals: GenericHealth Technology Part of SAWAI GROUP HOLDINGS Co., Ltd., Medisa Shinyaku, Inc. is a pharmaceutical company based in Osaka, Japan. The company's description is in Japanese, but it appears to be a subsidiary of Sawai Pharmaceutical Co., Ltd. and is involved in the manufacture and sale of pharmaceuticals. The private company has been updating its corporate information and has made several announcements regarding its business activities. | Director/Board Member | 2008-05-31 |
Kaken Shoyaku KK | Director/Board Member | 2007-05-31 |
Former positions of Minoru Kodama
Companies | Position | End |
---|---|---|
UFJ Bank Ltd. | Corporate Officer/Principal | - |
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Chief Administrative Officer | 2018-06-25 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
KAWAMOTO CORPORATION | Health Technology |
Private companies | 4 |
---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
UFJ Bank Ltd. | Finance |
Medisa Shinyaku, Inc.
Medisa Shinyaku, Inc. Pharmaceuticals: GenericHealth Technology Part of SAWAI GROUP HOLDINGS Co., Ltd., Medisa Shinyaku, Inc. is a pharmaceutical company based in Osaka, Japan. The company's description is in Japanese, but it appears to be a subsidiary of Sawai Pharmaceutical Co., Ltd. and is involved in the manufacture and sale of pharmaceuticals. The private company has been updating its corporate information and has made several announcements regarding its business activities. | Health Technology |
Kaken Shoyaku KK |
- Stock Market
- Insiders
- Minoru Kodama